0001209191-18-024845.txt : 20180413
0001209191-18-024845.hdr.sgml : 20180413
20180413165121
ACCESSION NUMBER: 0001209191-18-024845
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180331
FILED AS OF DATE: 20180413
DATE AS OF CHANGE: 20180413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassella James V
CENTRAL INDEX KEY: 0001353528
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 18754833
MAIL ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2018-03-31
2018-04-03
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001353528
Cassella James V
C/O CONCERT PHARMACEUTICALS, INC.
99 HAYDEN AVENUE, SUITE 500
LEXINGTON
MA
02421
0
1
0
0
Chief Development Officer
Common Stock
2018-03-31
4
F
0
4418
22.90
D
40582
D
Transaction represents withholding of shares to satisfy tax withholding obligations upon the vesting of restricted stock units.
This amendment is being filed to reduce the number of securities beneficially owned by the reporting person by 15,000 shares of common stock due to the failure to achieve certain performance criteria set forth in the restricted stock unit grant agreement with the reporting person dated July 6, 2017.
/s/ James V. Cassella
2018-04-13